Annual Accounts Payable
$3.47 M
-$59.00 K-1.67%
December 31, 2021
Summary
- As of February 10, 2025, MITO annual accounts payable is $3.47 million, with the most recent change of -$59.00 thousand (-1.67%) on December 31, 2021.
- During the last 3 years, MITO annual accounts payable has fallen by -$7.56 million (-68.55%).
Performance
MITO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$4.12 M
+$655.00 K+18.89%
March 31, 2022
Summary
- As of February 10, 2025, MITO quarterly accounts payable is $4.12 million, with the most recent change of +$655.00 thousand (+18.89%) on March 31, 2022.
- Over the past year, MITO quarterly accounts payable has dropped by -$498.00 thousand (-10.78%).
Performance
MITO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
MITO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.7% | -10.8% |
| 3 y3 years | -68.5% | -57.1% |
| 5 y5 years | -53.5% | -44.7% |
MITO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | at high | -15.9% |
| 5 y | 5-year | -63.6% | at low | -56.7% | -37.7% |
| alltime | all time | -68.5% | -16.1% | -62.6% | -37.7% |
Stealth BioTherapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $4.12 M(+18.9%) |
| Dec 2021 | $3.47 M(-1.7%) | $3.47 M(-11.4%) |
| Sep 2021 | - | $3.92 M(+52.6%) |
| Jun 2021 | - | $2.57 M(-44.5%) |
| Mar 2021 | - | $4.62 M(+31.0%) |
| Dec 2020 | $3.53 M | $3.53 M(+2.1%) |
| Sep 2020 | - | $3.45 M(-31.0%) |
| Jun 2020 | - | $5.00 M(-23.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2020 | - | $6.51 M(-31.6%) |
| Dec 2019 | $9.52 M(-13.6%) | $9.52 M(+30.7%) |
| Sep 2019 | - | $7.28 M(-18.8%) |
| Jun 2019 | - | $8.97 M(-6.6%) |
| Mar 2019 | - | $9.61 M(-12.9%) |
| Dec 2018 | $11.02 M(+47.9%) | $11.02 M(+24.9%) |
| Sep 2018 | - | $8.83 M(+18.4%) |
| Dec 2017 | $7.45 M(+156.2%) | $7.45 M |
| Dec 2016 | $2.91 M | - |
FAQ
- What is Stealth BioTherapeutics annual accounts payable?
- What is the all time high annual accounts payable for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics annual accounts payable year-on-year change?
- What is Stealth BioTherapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Stealth BioTherapeutics?
- What is Stealth BioTherapeutics quarterly accounts payable year-on-year change?
What is Stealth BioTherapeutics annual accounts payable?
The current annual accounts payable of MITO is $3.47 M
What is the all time high annual accounts payable for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high annual accounts payable is $11.02 M
What is Stealth BioTherapeutics annual accounts payable year-on-year change?
Over the past year, MITO annual accounts payable has changed by -$59.00 K (-1.67%)
What is Stealth BioTherapeutics quarterly accounts payable?
The current quarterly accounts payable of MITO is $4.12 M
What is the all time high quarterly accounts payable for Stealth BioTherapeutics?
Stealth BioTherapeutics all-time high quarterly accounts payable is $11.02 M
What is Stealth BioTherapeutics quarterly accounts payable year-on-year change?
Over the past year, MITO quarterly accounts payable has changed by -$498.00 K (-10.78%)